Molecular Partners AG - ADR logo

MOLN

Molecular Partners AG - ADR

$6.4

Earnings Summary

Revenue
$172.78Mn
Net Profits
$153.13Mn
Net Profit Margins
88.63%
PE Ratio
2.01

Highlights

Revenue:

Molecular Partners AG - ADR’s revenue jumped 21099.75% since last year same period to $172.78Mn in the Q1 2022. On a quarterly growth basis, Molecular Partners AG - ADR has generated 12420.14% jump in its revenue since last 3-months.

Net Profits:

Molecular Partners AG - ADR’s net profit jumped 1025.02% since last year same period to $153.13Mn in the Q1 2022. On a quarterly growth basis, Molecular Partners AG - ADR has generated 955.03% jump in its net profits since last 3-months.

Net Profit Margins:

Molecular Partners AG - ADR’s net profit margin jumped 104.36% since last year same period to 88.63% in the Q1 2022. On a quarterly growth basis, Molecular Partners AG - ADR has generated 106.83% jump in its net profit margins since last 3-months.

PE Ratio:

Molecular Partners AG - ADR’s price-to-earnings ratio after this Q1 2022 earnings stands at 2.01.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Molecular Partners AG - ADR post its latest quarter earnings

EPS Estimate Current Year
-1.04

Highlights

EPS Estimate Current Year:

Molecular Partners AG - ADR’s earning per share (EPS) estimates for the current year stand at -1.04.

Key Ratios

Key ratios of the Molecular Partners AG - ADR post its Q1 2022 earnings

Earning Per Share (EPS)
5
Return on Assets (ROA)
0.28
Return on Equity (ROE)
0.59
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Molecular Partners AG - ADR’s earning per share (EPS) jumped 923.12% since last year same period to 5 in the Q1 2022. This indicates that the Molecular Partners AG - ADR has generated 923.12% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Molecular Partners AG - ADR’s return on assets (ROA) stands at 0.28.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Molecular Partners AG - ADR’s return on equity (ROE) stands at 0.59.

Dividend Per Share (DPS):

Molecular Partners AG - ADR declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2020-09-30
0
-0.65
-Inf%

Company Information

Organisation
Molecular Partners AG - ADR
Headquarters
Schlieren, Zuerich, Switzerland
CEO
Patrick Amstutz